John F. Sheridan
Net Worth
Last updated:
What is John F. Sheridan net worth?
The estimated net worth of Mr. John F. Sheridan is at least $17,585,069 as of 15 Nov 2024. He owns shares worth $109,532 as insider, has earned $5,485,537 from insider trading and has received compensation worth at least $11,990,000 in Tandem Diabetes Care, Inc..
What is the salary of John F. Sheridan?
Mr. John F. Sheridan salary is $1,090,000 per year as Pres, Chief Executive Officer & Director in Tandem Diabetes Care, Inc..
How old is John F. Sheridan?
Mr. John F. Sheridan is 70 years old, born in 1955.
What stocks does John F. Sheridan currently own?
As insider, Mr. John F. Sheridan owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Tandem Diabetes Care, Inc. (TNDM) | Pres, Chief Executive Officer & Director | 10,058 | $10.89 | $109,532 |
What does Tandem Diabetes Care, Inc. do?
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. It has development and commercialization agreements with Dexcom, Inc. and Abbott Laboratories. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
John F. Sheridan insider trading
Tandem Diabetes Care, Inc.
Mr. John F. Sheridan has made 36 insider trades between 2014-2024, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 40,000 units of TNDM stock on 27 Feb 2019. As of 15 Nov 2024 he still owns at least 10,058 units of TNDM stock.
Tandem Diabetes Care key executives
Tandem Diabetes Care, Inc. executives and other stock owners filed with the SEC:
- Mr. Brian B. Hansen (57) Executive Vice President & Chief Commercial Officer
- Mr. David B. Berger (55) Executive Vice President, Chief Bus. Operations & Compliance Officer and Corporation Sec.
- Mr. John F. Sheridan (70) Pres, Chief Executive Officer & Director
- Ms. Leigh A. Vosseller (52) Executive Vice President, Chief Financial Officer & Treasurer
- Ms. Susan M. Morrison (46) Executive Vice President & Chief Admin. Officer